Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 470
Immune Disorders Drugs 198
Cardiovascular Drugs 156
Biopharmaceuticals 133
Infectious Diseases Drugs 128
Drug Discovery 122
Central Nervous System Drugs 107
Endocrine and Metabolic Disorders Drugs 104
Clinical Trials 101
Musculoskeletal Disorders Drugs 97
Pharmaceuticals 91
Leukemia Drugs 84
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 65
Dermatological Drugs 58
Diabetes Drugs 55
Brain Cancer Drugs 51
Skin Cancer Drugs 50
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Respiratory Drugs 39
Immunosuppressive Drugs 37
Gastrointestinal Drugs 35
Infusions and Injectables 32
Drug Delivery 32
Pharmaceutical Intermediates 31
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 28
Bladder Cancer Drugs 27
Analgesics 27
Drugs by Therapeutic Area 24
HIV/AIDS Drugs 23
Kidney Cancer Drugs 22
Antibiotics 22
Prostate Cancer Drugs 19
Colon Cancer Drugs 19
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Anti-Obesity Drugs 7
Cough and Cold Drugs 6
Company Reports 5
Anxiety Drugs 5
Pharmacoeconomics 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Vitamins and Dietary Supplements 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,434 Results (Page 23 of 122)
- Relevance
  Sort by

Cutaneous and Systemic Leishmaniasis - Global Strategic Business Report

 Report
October 2025
473 Pages
Global

From

€5193EUR$5,850USD£4,527GBP

Hospital Acquired Infection Treatment - Global Strategic Business Report

 Report
October 2025
194 Pages
Global

From

€5193EUR$5,850USD£4,527GBP

Cryptococcosis Treatment - Global Strategic Business Report

 Report
October 2025
193 Pages
Global

From

€5193EUR$5,850USD£4,527GBP

Encephalitis Treatment - Global Strategic Business Report

 Report
October 2025
478 Pages
Global

From

€5193EUR$5,850USD£4,527GBP

Neglected Tropical Disease Treatment - Global Strategic Business Report

 Report
October 2025
294 Pages
Global

From

€5193EUR$5,850USD£4,527GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Cryptococcosis Therapeutics - Global Strategic Business Report

 Report
October 2025
473 Pages
Global

From

€5193EUR$5,850USD£4,527GBP

Pseudomonas Aeruginosa Infection Treatment - Global Strategic Business Report

 Report
October 2025
273 Pages
Global

From

€5193EUR$5,850USD£4,527GBP

Europe Pharmaceutical Market Size, Share & Trends Analysis Report By Molecule, By Product (Branded, Generics), By Type (Prescription, OTC), By Disease, By Age Group, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

 Report
June 2025
250 Pages
Europe

From

€5281EUR$5,950USD£4,605GBP

Cancer Therapeutics and Biotherapeutics - Global Strategic Business Report

 Report
October 2025
419 Pages
Global

From

€5193EUR$5,850USD£4,527GBP

ADC Technology Market: Focus on ADC Linker and ADC Conjugation Technologies (2nd Edition) - Distribution by Generation of ADC Technology, Type of Conjugation, Type of Linker and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

 Report
July 2023
407 Pages
Global

From

€4260EUR$4,799USD£3,714GBP

Pharmerging - Global Strategic Business Report

 Report
October 2025
184 Pages
Global

From

€5193EUR$5,850USD£4,527GBP

Critical Care Therapeutics - Global Strategic Business Report

 Report
October 2025
280 Pages
Global

From

€5193EUR$5,850USD£4,527GBP

Lung Cancer Diagnosis and Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
118 Pages
Global

From

€3500EUR$4,224USD£3,158GBP

Generic Oncology Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3985EUR$4,490USD£3,475GBP

Non-Alcoholic Steatohepatitis Treatment Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3985EUR$4,490USD£3,475GBP

End Stage Renal Disease (ESRD) Drug Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3985EUR$4,490USD£3,475GBP

Nephrology Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3985EUR$4,490USD£3,475GBP

Focal Segmental Glomerulosclerosis Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3985EUR$4,490USD£3,475GBP

Primary Biliary Cholangitis Therapeutics Market

 Report
January 2024
200 Pages
Global

From

€3684EUR$4,150USD£3,212GBP

Squamous Non-Small Cell Lung Cancer Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
October 2024
99 Pages
Global

From

€3500EUR$4,224USD£3,158GBP

2,434 Results (Page 23 of 122)
- 1
- 21
- 22
- 23
- 24
- 25

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.